Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-02-24-Speech-3-256"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-02-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:One-minute speeches on matters of political importance2
dcterms:Language	"ro"^^xsd:language2
lpv:document identification number	"en.20100224.20.3-256"2
lpv:hasSubsequent	lp_eu:2010-02-24-Speech-3-2572
lpv:speaker	lp:Claudiu Ciprian Tănăsescu2
lpv:spokenAs	member; ENVI (2009-07-16--2012-01-18)3 member; NA (2009-07-14--2010-11-14)3 substitute; Delegation for relations with the Korean Peninsula (2009-09-16--2010-11-14)3 member; Delegation for relations with Canada (2009-09-16--2014-06-30)3 unknown; Partidul România Mare (2009-07-14--2010-11-14)3
lpv:translated text	"Due to the expiry of its GMP standard in early February, the Cantacuzino National Institute of Research and Development for Microbiology and Immunology, based in Bucharest, has had its licence withdrawn for manufacturing and marketing injectable products, including vaccines. Following the implementation of the corrective action plan drawn up by the management of the Cantacuzino Institute, along with the National Medicines Agency, and approved by the Ministry of Health, the Cantacuzino Institute is expected to regain authorisation to manufacture vaccines in the second half of April. However, we should not forget that discontinuation of the operation of an institute of national and European strategic importance, such as the Cantacuzino Institute, entails a high potential hazard. This is why I believe that it is important for European institutions to exert tighter control, which will prevent the recurrence of such a situation at European level in the future."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph